Malta David Valenzia, territory senior partner at PwC Malta, gives his insights on the evolution of the healthcare industry in Malta as well as the key role of PwC in assisting local and global companies to successfully conduct their business on the island. PwC is one of the leading professional services…
Canada Moving into the position of National Pharma & Life Sciences Leader, PwC’s Rami El-Cheikh announces the firm’s plan to introduce the comprehensive Pharma Advisory Services currently existing in the US into Canada, including enterprise and function-specific service expertise. He further identifies areas of potential growth in healthcare-related industries, putting forward…
Poland Mariusz Ignatowicz, PwC healthcare sector leader for CEE, discusses the funding of the Polish healthcare ecosystem and the need to find an alternative payer in the long-term Additionally, he highlights PwC’s services and the overall requirement for data to be taken into more consideration in Polish healthcare to ensure accurate…
Ireland Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC. She also expands on the exciting opportunities that exist in the country to leverage the pharma and tech markets to…
Healthcare PharmaBoardroom has spoken to a wide variety of actors at the cutting edge of healthcare digitalization over the past 12 months. Hot topics have included the healthcare industry’s slow reaction to digital trends, new modes of hospital care, homecare, and digitalization’s potential to expand access in remote and underdeveloped areas.…
Asia Despite underdevelopment in many facets; Southeast Asia is actually at the forefront of a digital revolution in healthcare; with digital solutions helping bring about more efficient, cost-effective, and tailored patient care. “Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients.…
Pharma PwC Italy’s Rodrigue G. Schübelin talks maintaining Italy’s impressive growth in pharma production, R&D incentives, public-private collaboration, and PwC’s role within the Italian healthcare ecosystem. Italy’s pharmaceutical production increased by 38 percent from 2009 to 2014; what steps does the industry need to take to keep performing at this level?…
Pharma PwC France’s pharma and life sciences industry leader speaks out about the consultancy’s positioning as partner of choice for advisory services in the pharmaceutical industry with more than 75 percent of the local market now registered as clients. She also reflects upon the likely repercussions of digital disruption on the…
PwC The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand how health impacts on the economic growth of the country. Back in 2012 you told us that the…
advisory Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the industry given the current economic context. What are the key trends in the Argentinian pharmaceutical market at present? The…
Biosimilars Audrey Tseng, Deputy Chairman of PwC Taiwan with PwC Partners Lily Wong and Andy Chang, delve into factors behind the booming pharma and biotech industry in Taiwan, how to prevent a bubble burst, and the crucial next steps in maintaining the momentum to continue growth within the industry. Please start…
Life Sciences Wayne Samuels, partner at PwC Canada, discusses the most pressing issues in the country’s healthcare system and pharmaceutical industry, and outlines the changing dynamics in Canada’s pharma business model. What have been some of the key developments in life sciences during your tenure at PwC Canada so far? The most…
See our Cookie Privacy Policy Here